Q SQUARED SOLUTIONS HOLDINGS LIMITED
Get an alert when Q SQUARED SOLUTIONS HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-06-26 (in 1mo)
Last made up 2025-06-12
Watchouts
None on the register
Cash
£738K
+822.5% vs 2023
Net assets
£271M
+5.6% vs 2023
Employees
0
Average over period
Profit before tax
£86M
+169.6% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£5,000 | -£7,000 | |
| Profit before tax | £32,019,000 | £86,332,000 | |
| Net profit | £31,885,000 | £86,467,000 | |
| Cash | £80,000 | £738,000 | |
| Total assets less current liabilities | £256,813,000 | £271,280,000 | |
| Net assets | £256,813,000 | £271,280,000 | |
| Equity | £256,813,000 | £271,280,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — | |
| Directors' remuneration | £0 | £0 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+822.5%
£80,000 £738,000
-
Net assets
+5.6%
£256,813,000 £271,280,000
-
Employees
—
Not reported
-
Operating profit
-40%
-£5,000 -£7,000
-
Profit before tax
+169.6%
£32,019,000 £86,332,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -0.0% | -0.0% | |
| Current ratio | 14.55x | 19.83x | |
| Interest cover | -0.04x | — |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- Q SQUARED SOLUTIONS HOLDINGS LIMITED 2015-07-01 → present
- CLINICAL LAB JV LIMITED 2015-06-12 → 2015-07-01
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis. The company meets its day-to-day working capital requirements through its cash reserves and borrowings. The Company should be able to operate within the level of its current cash resources and borrowings. After making enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.”
Group structure
- Q SQUARED SOLUTIONS HOLDINGS LIMITED · parent
- Clinical Lab Minority Shareholder Limited 100%
- Q Squared Solutions China (Quest) Limited 100%
- Q Squared Solutions Proprietary Limited 100%
- Q Squared Solutions China Limited 100%
- Q Squared Solutions Holding BV 100%
- Q Squared Solutions KK 100%
- Q Squared Solutions Pte Ltd 100%
- Q Squared Solutions Limited 100%
- Q Squared Solutions S.A. 90%
- Q Squared Solutions (Quest) Limited 100%
- Q Squared Solutions BV 100%
- Q Squared Solutions (Beijing) Co.Limited 100%
- Q Squared Solutions S.A. 10%
Significant events
- “On 1 April 2021, IQVIA Biotech Ltd, a fellow group undertaking acquired the 40% minority share of Q Squared Solutions Holdings Limited from Quest Diagnostics Subsidiary Holdings Ltd for £253,520,333, resulting in 100% ownership by IQVIA.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WILLIFORD, John | Secretary | 2020-01-01 | — | — |
| JTC (UK) LIMITED | Corporate Secretary | 2023-06-29 | — | — |
| LOWEY, Elaine | Director | 2024-07-31 | Oct 1978 | British |
| THORNLEY, Simon Carwyn | Director | 2022-08-25 | Feb 1972 | British |
| TURLAND, Kevin John | Director | 2022-08-25 | Mar 1969 | British |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BROOKS, Marc | Secretary | 2015-07-01 | 2017-02-08 |
| ESTRADA, Santiago | Secretary | 2017-02-09 | 2019-12-31 |
| FOVARGUE, Helen | Secretary | 2017-02-09 | 2019-11-01 |
| BROWN, Tony | Director | 2022-08-25 | 2024-07-31 |
| BROWN STAFFORD, Paula | Director | 2015-07-01 | 2016-01-01 |
| BRUEHLMAN, Ronald Earl | Director | 2017-02-09 | 2022-08-25 |
| FONSECA, Lidia | Director | 2017-02-09 | 2019-02-13 |
| FUNK, Randy Lee | Director | 2019-02-11 | 2021-04-01 |
| GORDON, Kevin Karl | Director | 2015-07-01 | 2016-10-03 |
| GUINAN, Mark James | Director | 2018-05-17 | 2021-04-01 |
| HAYDON, John Bradley | Director | 2015-07-01 | 2018-05-17 |
| LORENZ, Rene | Director | 2016-10-04 | 2022-08-25 |
| MACDONALD, Alasdair | Director | 2015-06-12 | 2015-07-01 |
| NORMAN, Jay | Director | 2015-07-01 | 2017-02-08 |
| PANAGOS, Constantinos | Director | 2017-02-09 | 2018-09-10 |
| RALPHSON, Neil | Director | 2015-07-01 | 2018-05-17 |
| SHORTEN, Dermot Victor | Director | 2015-07-01 | 2017-02-08 |
| SPAEDER, Jeffrey | Director | 2020-06-05 | 2022-08-25 |
| STEWART, Wendy | Director | 2018-05-17 | 2022-08-25 |
| VERST, Cynthia | Director | 2018-09-10 | 2020-06-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Iqvia Biotech Ltd. | Corporate entity | Shares 25–50%, Voting 25–50% | 2021-04-01 | Active |
| Quest Diagnostics Subsidiary Holdings Ltd | Corporate entity | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2021-04-01 |
| Iqvia Ltd. | Legal person | Shares 50–75% | 2016-04-06 | Ceased 2016-04-06 |
| Iqvia Ltd. | Corporate entity | Shares 50–75%, Voting 50–75%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 104 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-07-08 | AA | accounts | Accounts with accounts type full | |
| 2025-06-20 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-12-10 | SH01 | capital | Capital allotment shares | |
| 2024-12-09 | SH01 | capital | Capital allotment shares | |
| 2024-08-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-10 | AA | accounts | Accounts with accounts type full | |
| 2024-06-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-06 | CH01 | officers | Change person director company with change date | |
| 2023-10-09 | AD02 | address | Change sail address company with old address new address | |
| 2023-10-06 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2023-07-15 | AA | accounts | Accounts with accounts type full | |
| 2023-06-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-01-19 | AAMD | accounts | Accounts amended with accounts type full | |
| 2022-09-07 | AA | accounts | Accounts with accounts type full | |
| 2022-08-31 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-31 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-31 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-31 | AP01 | officers | Appoint person director company with name date | |
| 2022-08-31 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.